MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

SP-141

CAS No. : 1253491-42⁻⁷

MCE 国际站：SP-141

产品活性：SP-141 是一种特异性的 MDM2 抑制剂。SP-141 促进 MDM2 自泛素化和降解。SP-141 可用于胰腺癌和乳腺癌的研究。

研究领域：Apoptosis

作用靶点：MDM-2/p53

In Vitro: SP-141 (0.01-10 µM; 72 hours) inhibits human pancreatic cancer cell growth with IC₅₀ values of less than 0.5 µM (0.38-0.50 µM) in a p53-independent manner. The IMR90 cells are much less sensitive to SP141 than the pancreatic cancer cells, suggesting that SP141 has a selective cytotoxicity for cancer cells.
SP141 induces MDM2 auto-ubiquitination and proteasomal degradation in both HPAC and Panc-1 cells.

In Vivo: SP-141 (40 mg/kg; administered by i.p. injection; 5 d/wk for about three weeks) suppresses pancreatic tumor growth in both xenograft and orthotopic mouse models.

相关产品：Bioactive Compound Library Plus | Apoptosis Compound Library | Anti-Cancer Compound Library | Autophagy Compound Library | Anti-Aging Compound Library | Ferroptosis Compound Library | Pyroptosis Compound Library | Glutamine Metabolism Compound Library | Anti-Breast Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Nutlin-3a | Pifithrin-α hydrobromide | Eprenetapopt | Amifostine | Pifithrin-µ | RITA | MI⁻⁷73 | Pifithrin-α, p-Nitro, Cyclic | NSC319726 | Amifostine thiol dihydrochloride | PK11007 | Solasodine | Inauhzin | SJ-172550 | CTX1 | Kevetrin hydrochloride | MX69 | ReACp53 | RO8994 | PhiKan 083 | Ziyuglycoside I | DPBQ | PK11000 | NSC 66811 | Triglycidyl isocyanurate

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。